EMA mAb Workshop – Stepwise Approach to Non-Clinical Program
International Generic Pharmaceutical Alliance (IGPA) Letter Regarding TGA Guidance Titled “Evaluation of Biosimilars”, 2013
Safe Prescription,Safe Dispensing, Identification and Track&Trace of All Biologicals in the Context of the Re-opened Biosimilars INN Debate – 11th EGA Symposium on Biosimilar Medicines, Suzette Kox, London 2013
Biosimilar Monoclonal Antibodies – 11th EGA International Symposium on Biosimilar Medicines, Gudbjorg Edda Eggertsdottir, London, 25 April 2013
Production and Control of Biosimilars versus Innovators, Biosimilars Present and Future – Da Silva, Infarmed, Lisbon, 3 April 2013 (PPT)
Emergence of Biosimilar Medicines – The Biosimilar Company Point of View, Paul Greenland, Belgium Federal Parliament, Brussels, 22 November 2012 (PPT)
EMA Questions and Answers on Biosimilar Medicines (Similar Biological Medicinal Products)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
